Cairo — Egypt has identified more than 17 million previously undocumented genetic variants in its first large-scale genome analysis, marking a significant milestone in understanding the country’s genetic composition and advancing future healthcare strategies.
According to findings from the Egypt Genome Project published on April 6, researchers analysed genetic data from 1,024 individuals across 21 governorates, generating one of the most comprehensive datasets on Egyptian DNA to date. As The Middle East Observer notes, the study addresses a longstanding gap in global genetic research, where Middle Eastern and North African populations have historically been underrepresented.
The research identified more than 51 million genetic variants overall, with approximately one-third not recorded in international databases, underscoring significant gaps in existing global genomic references. Scientists involved in the project indicated that Egyptians exhibit a distinct genetic profile that combines shared Middle Eastern ancestry with a unique North African component, offering new insights into population-specific health patterns.
The Middle East Observer understands that these findings could have far-reaching implications for medical practice in Egypt, particularly as many diagnostic and risk assessment models are currently based on European populations. When such international models were applied to the Egyptian sample, they indicated elevated risk levels for several conditions—an outcome researchers attribute to limitations in the models rather than actual disease prevalence.
The study also highlighted relatively high carrier rates for certain inherited conditions, including Familial Mediterranean Fever, alongside regional variations linked to patterns such as consanguineous marriages. These insights, as observed by The Middle East Observer, could support the development of more targeted screening programmes and enable a shift toward personalized healthcare approaches.
Currently published as a preprint, the research is expected to expand in future phases, contributing to the establishment of a comprehensive national genetic database aimed at improving diagnosis, treatment, and public health planning across Egypt.
